Fairpointe Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $751K | Sell |
11,619
-2,600
| -18% | -$168K | 1.13% | 29 |
|
|
2020
Q4 | $828K | Buy |
14,219
+2,453
| +21% | +$143K | 0.15% | 56 |
|
|
2020
Q3 | $743K | Sell |
11,766
-785
| -6% | -$49.6K | 0.12% | 54 |
|
|
2020
Q2 | $966K | Sell |
12,551
-5,665
| -31% | -$436K | 0.14% | 53 |
|
|
2020
Q1 | $1.36M | Buy |
18,216
+3,216
| +21% | +$240K | 0.2% | 51 |
|
|
2019
Q4 | $975K | Hold |
15,000
| – | – | 0.07% | 54 |
|
|
2019
Q3 | $951K | Hold |
15,000
| – | – | 0.05% | 56 |
|
|
2019
Q2 | $1.01M | Hold |
15,000
| – | – | 0.04% | 55 |
|
|
2019
Q1 | $975K | Hold |
15,000
| – | – | 0.03% | 56 |
|
|
2018
Q4 | $938K | Buy |
15,000
+5,000
| +50% | +$313K | 0.03% | 57 |
|
|
2018
Q3 | $772K | Hold |
10,000
| – | – | 0.02% | 61 |
|
|
2018
Q2 | $708K | Buy |
+10,000
| New | +$708K | 0.02% | 62 |
|